<p>Nanoparticle (NP) exposure has been implicated in accelerating atherosclerosis, while phytochemicals like epigallocatechin gallate (EGCG) may counteract these effects through metabolic modulation. This study investigates whether EGCG mitigates SiO<sub>2</sub> NP-induced foam cell formation in atherosclerotic mice by restoring metabolic homeostasis. ApoE-/- mice were administered 1600&#xa0;mg/kg SiO<sub>2</sub> NPs, 80&#xa0;mg/kg EGCG, or both, via daily intragastric gavage for totally 28 days. Although SiO<sub>2</sub> NPs did not significantly alter cardiac contractile function or increase Oil Red O-positive areas in entire aortas, they markedly elevated BODIPY 493/503-positive lipid accumulation in the aortic sinus, whereas co-treatment with EGCG completely abrogated this effect. Metabolomic profiling revealed distinct perturbations induced by SiO<sub>2</sub> NPs versus SiO<sub>2</sub> NPs + EGCG. SiO<sub>2</sub> NPs up-regulated amino acids (L-norvaline, leucine, N-acetylalanine) and fatty acids (decanoic acid, trans-vaccenic acid, octanoic acid) but down-regulated nucleotides (cAMP, adenine, AMP), while EGCG co-exposure reversed these changes. Pathway enrichment analysis indicated that SiO<sub>2</sub> NPs + EGCG co-exposure more profoundly affected porphyrin metabolism (map00860) and fatty acid biosynthesis (map00061) compared to SiO<sub>2</sub> NPs alone. Western blotting demonstrated SiO<sub>2</sub> NP-induced activation of autophagy (increased LC3-II/I ratio) and apoptosis (increased pro-caspase 3 and cleaved caspase 3) in aortic tissue, effects reversed by EGCG. Additionally, EGCG enhanced expression of Kruppel-like factor 4 (KLF4), a key regulator of vascular homeostasis, on the lumen surface. Collectively, oral SiO<sub>2</sub> NP exposure exacerbates early atherosclerotic progression through metabolic dysregulation and activation of autophagy-apoptosis pathways, while EGCG counteracts these effects by restoring metabolic balance and regulating KLF4.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Oral Exposure To SiO2 Nanoparticles Promotes Foam Cell Areas in Aortic Sinus of ApoE-/- Mice and Epigallocatechin Gallate Attenuates the Effects via Metabolic Restoration

  • Xiaomei Zhao,
  • Kuanhang Li,
  • Qing Liu,
  • Miao Jiang,
  • Yi Cao

摘要

Nanoparticle (NP) exposure has been implicated in accelerating atherosclerosis, while phytochemicals like epigallocatechin gallate (EGCG) may counteract these effects through metabolic modulation. This study investigates whether EGCG mitigates SiO2 NP-induced foam cell formation in atherosclerotic mice by restoring metabolic homeostasis. ApoE-/- mice were administered 1600 mg/kg SiO2 NPs, 80 mg/kg EGCG, or both, via daily intragastric gavage for totally 28 days. Although SiO2 NPs did not significantly alter cardiac contractile function or increase Oil Red O-positive areas in entire aortas, they markedly elevated BODIPY 493/503-positive lipid accumulation in the aortic sinus, whereas co-treatment with EGCG completely abrogated this effect. Metabolomic profiling revealed distinct perturbations induced by SiO2 NPs versus SiO2 NPs + EGCG. SiO2 NPs up-regulated amino acids (L-norvaline, leucine, N-acetylalanine) and fatty acids (decanoic acid, trans-vaccenic acid, octanoic acid) but down-regulated nucleotides (cAMP, adenine, AMP), while EGCG co-exposure reversed these changes. Pathway enrichment analysis indicated that SiO2 NPs + EGCG co-exposure more profoundly affected porphyrin metabolism (map00860) and fatty acid biosynthesis (map00061) compared to SiO2 NPs alone. Western blotting demonstrated SiO2 NP-induced activation of autophagy (increased LC3-II/I ratio) and apoptosis (increased pro-caspase 3 and cleaved caspase 3) in aortic tissue, effects reversed by EGCG. Additionally, EGCG enhanced expression of Kruppel-like factor 4 (KLF4), a key regulator of vascular homeostasis, on the lumen surface. Collectively, oral SiO2 NP exposure exacerbates early atherosclerotic progression through metabolic dysregulation and activation of autophagy-apoptosis pathways, while EGCG counteracts these effects by restoring metabolic balance and regulating KLF4.